The AI Clinical Platform for Neurosurgery
Objective measures.
A clearer patient journey.
Combining functional, imaging and cognitive AI
to quantify patient status, treatment response and recovery.
RESEARCH & CLINICAL DEVELOPMENT
INITIAL CLINICAL PATHWAYS
Normal pressure hydrocephalus
NPH
Degenerative cervical myelopathy
DCM
THE CLINICAL NEED
Surgical decisions need a clearer picture of patient function.
Before intervention and throughout recovery, clinicians need to understand how patients move, how they change and what that change means.
Neurogait translates video-based assessments into objective functional measurements, with a platform vision that connects imaging and clinical context for longitudinal review.
THE PLATFORM
Multimodal AI.
One patient view.
A shared AI architecture brings objective movement measures, quantitative imaging markers and cognitive assessments into the clinical workflow.
Video-based functional assessment
SMARTPHONE VIDEO + AI
Make movement measurable.
Computer vision and machine learning translate smartphone recordings of gait and hand movements into objective functional measures — designed for comparison across visits.
INPUT
Gait · Finger tapping · Hand tremor
CLINICAL CONTEXT
A longitudinal view of patient function
DEVELOPMENT FOCUS
Clinical validation in neurosurgical pathways
.webp)
INITIAL CLINICAL APPLICATIONS
Built around the decisions
that shape patient care.
.webp)
01 / NPH
Shunt evaluation
and follow-up
Combine a functional baseline, post-test change and imaging context. Follow the patient’s trajectory after shunt surgery.
One multimodal AI architecture, with clinical evidence developed for each surgical pathway.
02 / DCM
Function before surgery.
Recovery after it.
Quantify gait and motor performance before intervention, then review changes alongside established clinical assessments.
THE SURGICAL JOURNEY
Follow the patient.
Understand the change.
Our development starts with normal pressure hydrocephalus (NPH) and degenerative cervical myelopathy (DCM).
01 / BEFORE SURGERY
Establish the baseline.
Bring objective functional measures and assessment context into the clinical evaluation.
02 / ACROSS ASSESSMENTS
Connect the evidence.
Explore changes across tests and visits to support a more informed clinical discussion.
03 / AFTER SURGERY
Track recovery.
Follow function over time and make change visible alongside established outcome measures.
These are development objectives. Patient selection and outcome prediction require additional clinical validation and appropriate regulatory clearance.
CLINICAL DEVELOPMENT
A growing clinical foundation.
SHEBA MEDICAL CENTER
47
participants in the initial study
Prospective proof of concept
Completed in 2023 across NPH, Parkinson’s disease and healthy controls. The early study forms a foundation for continued assessment development.
We are building from early gait research toward prospective validation in neurosurgical care.
Retrospective study · 2026
Shaare Zedek Medical Center
A secured dataset of 82 NPH patients with matched CT and longitudinal gait assessments, before and after LP and surgery. Helsinki submission underway.
Signed pilots · Execution ahead
LMU Hospital, Munich
Planned studies span NPH shunt evaluation (50 patients), DCM surgical care (50 patients), and community NPH / Parkinson’s assessment (150 participants). Approvals and execution remain ahead.
Development & regulatory status
Neurogait is under development and is not currently CE marked or FDA cleared. Clinical decisions remain with qualified healthcare professionals. Availability and intended uses will depend on validation and regulatory authorization.
OUR TEAM
The people behind Neurogait.
Clinicians, technology leaders and healthcare entrepreneurs working toward a clearer understanding of neurological function.
Eyal Fruchtman
CEO & Co-founder
Ben Francke
Business Development & Co-founder
Prof. Gilad Yahalom
Medical Director & Co-founder
Remi Rozycki
CTO
COMMON QUESTIONS
BUILD WITH US
Bring clinical intelligence
to your research program.
Discuss a research collaboration, explore the platform, or start a conversation about an industry partnership.